Clincosm LogoSign in Get a demo

mds

Showing 1 - 25 of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • Los Angeles, California
  • +13 more
Apr 12, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

MDS Trial (Yisui granule, Placebo)

Not yet recruiting
  • MDS
  • Yisui granule
  • Placebo
  • (no location specified)
Jan 13, 2023

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Acute Leukemia, MDS Trial in Chicago (device, drug, other)

Recruiting
  • Acute Leukemia
  • MDS
  • Arm1
  • Arm 1
  • Chicago, Illinois
    University of Illinois Cancer Center
Oct 13, 2022

Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +3 more
  • Venetoclax plus RIC
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Oct 12, 2022

Lower-risk MDS Patients

Recruiting
  • MDS
    • Leipzig, Germany
      University Hospital Leipzig
    Oct 13, 2022

    MDS, Systemic Autoimmune Diseases Trial in France (Azacitidine)

    Completed
    • MDS
    • Systemic Autoimmune Diseases
    • Amiens cedex 01, France
    • +58 more
    Oct 3, 2022

    AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

    Recruiting
    • AML
    • MDS
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 29, 2022

    Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

    Terminated
    • Myelodysplastic Syndrome
    • +3 more
    • La Jolla, California
    • +157 more
    Sep 22, 2022

    Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD Trial in Austria, Germany, Italy

    Recruiting
    • Mitochondrial Diseases
    • +17 more
      • Innsbruck, Austria
      • +18 more
      Sep 23, 2022

      MDS, AML Trial in Austria, Germany (CPX-351, Daunorubicin, Cytarabine)

      Recruiting
      • MDS
      • AML
      • Linz, Austria
      • +26 more
      Sep 9, 2022

      GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)

      Recruiting
      • GATA2
      • +2 more
      • Allogeneic HSCT
      • +8 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

      Recruiting
      • Graft Vs Host Disease
      • +5 more
      • Augsburg, Germany
      • +15 more
      Aug 2, 2022

      Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

      Not yet recruiting
      • Hematologic Malignancy
      • +10 more
      • Los Angeles, California
      • +28 more
      Jul 26, 2022

      MDS, AML Trial in Bronx (Venetoclax, Decitabine)

      Recruiting
      • MDS
      • AML
      • Bronx, New York
        Montefiore Medical Center
      Jul 22, 2022

      MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)

      Not yet recruiting
      • MDS
      • AML
      • venetoclax + azacitidine +/- donor lymphocyte infusion
      • Amiens, France
      • +13 more
      Jul 21, 2022

      MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

      Recruiting
      • MDS
      • AML
      • Amiens, France
      • +15 more
      Jul 21, 2022

      MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

      Terminated
      • MDS
      • Myelodysplastic Syndromes
      • APR-548 + Azacitidine
      • Tampa, Florida
      • +3 more
      Jul 20, 2022

      Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

      Recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Duarte, California
      • +7 more
      Jul 20, 2022

      AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

      Recruiting
      • AML, Adult
      • +3 more
      • Shreveport, Louisiana
      • +3 more
      Jul 19, 2022

      AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

      Recruiting
      • AML
      • +6 more
      • Gilbert, Arizona
      • +7 more
      Jul 8, 2022